Phage Therapy for Multi-Drug Resistant Respiratory Tract Infections
The emergence of multi-drug resistant (MDR) bacteria is recognised today as one of the greatest challenges to public health. As traditional antimicrobials are becoming ineffective and research into new antibiotics is diminishing, a number of alternative treatments for MDR bacteria have been receivin...
Main Authors: | Joshua J. Iszatt, Alexander N. Larcombe, Hak-Kim Chan, Stephen M. Stick, Luke W. Garratt, Anthony Kicic |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/9/1809 |
Similar Items
-
Unexploited opportunities for phage therapy
by: Hugo eOliveira, et al.
Published: (2015-09-01) -
Overcoming Challenges to Make Bacteriophage Therapy Standard Clinical Treatment Practice for Cystic Fibrosis
by: Renee N. Ng, et al.
Published: (2021-01-01) -
Phage sensitivity profiles of a nasopharyngeal opportunistic pathogen in Streptococcus pneumoniae carrier children with recurrent respiratory infections
by: L T Bayazitova, et al.
Published: (2020-06-01) -
Potential value of bacteriocins in the etiological treatment of infectious diseases of the respiratory tract
by: А.Е. Abaturov, et al.
Published: (2017-10-01) -
The therapeutic potential of bacteriophages and endolysins in the treatment of acute respiratory infections caused by bacterial pathogens
by: А.Е. Abaturov, et al.
Published: (2017-09-01)